Interpace Biosciences, Inc. Stock
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.450 USD | -3.97% |
|
-6.45% | +17.87% |
| Market Cap | 40.17M 35.33M 32.82M 30.18M 56.6M 3.89B 57.62M 392M 153M 1.9B 151M 148M 6.58B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 38.84M 34.16M 31.74M 29.19M 54.74M 3.76B 55.72M 380M 148M 1.83B 146M 143M 6.37B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.97% | ||
| 1 week | -6.45% | ||
| Current month | -11.04% | ||
| 1 month | -13.69% | ||
| 3 months | -28.32% | ||
| 6 months | -16.18% | ||
| Current year | +17.87% |
| 1 week | 1.34 |  | 1.51 |
| 1 month | 1.34 | | 1.8 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.77 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.5 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 2020-11-30 |
| Director of Finance/CFO | 34 | 2023-04-20 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 2016-06-20 |
Joseph Keegan
BRD | Director/Board Member | 73 | 2015-12-31 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 2020-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/20/26 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 1/20/26 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 2/1/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.97% | -6.45% | +42.16% | -33.49% | 41.83M | |
| +0.18% | -1.90% | +92.05% | +436.79% | 37.84B | |
| +3.40% | +3.22% | +16.17% | +32.76% | 23.08B | |
| -0.43% | -5.06% | -26.18% | -41.86% | 7.19B | |
| +2.97% | -3.19% | +4.17% | +74.28% | 4.66B | |
| -0.70% | -2.10% | +12.32% | +47.54% | 2.94B | |
| +1.64% | -4.04% | +115.43% | -18.35% | 1.82B | |
| +1.25% | +2.74% | -23.59% | +703.30% | 1.86B | |
| -2.18% | -5.42% | -8.99% | -62.78% | 1.85B | |
| +7.66% | +0.97% | +14.27% | +5.81% | 1.79B | |
| Average | +0.95% | -2.16% | +23.78% | +114.40% | 8.31B | |
| Weighted average by Cap. | +1.28% | -1.88% | +46.96% | +224.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.27M 38.34M 35.26M 66.13M 4.54B 67.32M 458M 179M 2.22B 176M 172M 7.69B | 38.73M 34.06M 31.64M 29.1M 54.58M 3.75B 55.56M 378M 148M 1.83B 145M 142M 6.35B |
| Net income | 6.7M 5.89M 5.48M 5.04M 9.44M 649M 9.61M 65.48M 25.54M 317M 25.16M 24.62M 1.1B | 24.58M 21.61M 20.08M 18.47M 34.63M 2.38B 35.25M 240M 93.65M 1.16B 92.26M 90.26M 4.03B |
| Net Debt | 4.4M 3.87M 3.59M 3.3M 6.19M 426M 6.3M 42.94M 16.75M 208M 16.5M 16.14M 720M | -1.32M -1.16M -1.08M -993K -1.86M -128M -1.9M -12.92M -5.04M -62.44M -4.96M -4.86M -217M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$1.450 | -3.97% | 2,536 |
| 26-07-22 | US$1.510 | +0.37% | 4,632 |
| 26-07-21 | US$1.504 | +0.97% | 1,217 |
| 26-07-20 | US$1.490 | -2.30% | 4,423 |
| 26-07-17 | US$1.525 | -1.61% | 2,060 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
